Thursday, June 4, 2015

Top 5 Information Technology Companies To Own For 2015

With shares of Boeing (NYSE:BA) now trading around $104, is BA an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Boeing is an aerospace company. It focuses primarily on engineering, information technology, research and development, test and evaluation, technology strategy development, environmental remediation management and intellectual property management. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital Corporation.

On Saturday, Boeing’s 777 jet crashed in San Francisco, but luckily, the plane had several built-in safety features that helped save lives in the accident. One of the greatest features of the 777 jet is a flame-retardant cabin, and engineering that ensured the plane wouldn�� break up too much after the impact. For now, it doesn’t appear as though any mechanical failure caused the crash, which is good news for Boeing after the safety issues that have plagued the company’s other aircrafts this year.�As a leading provider of aerospace products and services to large corporations, not to mention the U.S. government, look for Boeing to continue to advance and develop this space and fuel aerial progress.

Top 10 Construction Stocks To Invest In 2016: Vision Industries Corp (VIIC)

Vision Industries Corp. (Vision), incorporated on May 11, 2004, is a manufacturer of zero-emission hydrogen fuel cell electric hybrid powered Class 8 trucks and terminal tractors. Vision operates in the short-haul, drayage trucking category (the movement of containerized cargo over a short distance, typically less than 50 miles, from a port to an intermodal facility, such as a rail yard). The Company�� products include the Tyrano, a short-haul Class 8 tractor, and the Zero-TT, a single axle terminal tractor co-developed with Cargotec USA, the maker of terminal tractors.

The Company markets its vehicles to drayage operators at the twin Ports of Los Angeles and Long Beach and plans to expand its target market nationally to all fleet operators, owner-operators and Original Equipment Manufacturers (OEMs). Vision aims to target drayage trucking fleet operators who operate in the eight deep-water ports (Los Angeles, Long Beach, Oakland, Seattle, Houston, Savanah, New York and New Jersey). Fleets which operate at these locations usually have predetermine routes, travel less than 50-mile (from Port to rail yard or distribution center) and have a return to base duty-cycle.

Tyrano

The Vision Tyrano is a lass 8 Zero-Emission Hydrogen Fuel Cell / Electric Hybrid heavy-duty truck designed to move containerized cargo from port to rail yard. With a GCVWR the Tyrano uses Lithium-ion batteries to power an electric motor and Hydrogen fuel cells to extend its range. The Vision Tyrano was designed for short-distance containerized cargo movement with trade corridor communities in mind.

Vision (Zero-TT) Terminal Tractors

The Zero-Emission Terminal Tractor (Zero-TT) is a Class 8 facility-only Hydrogen Fuel Cell Electric Hybrid vehicle. GCVWR and is designed to move the heavy containerized cargo inside a Port facility or central distribution center. The Zero-TT is designed to operate for two full eight-hour shifts with refillable hydrogen tanks.

Cheetah

The Cheetah Supercar is a zero-emission passenger sports car prototype. This sports car is using Vision�� hybrid hydrogen drive system which can deliver 425 horsepower and 1,350 feet /lbs of torque.

The Company competes with Bosch, Delphi, Siemens, Visteon, Quantum, Dynetek Industries Ltd., Lincoln Composites, Structural Composites Inc, Linde AG, Air Products and Energy Conversion Devices.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap green stocks Vision Industries Corp (OTCMKTS: VIIC), Bravo Enterprises Ltd (OTCMKTS: OGNG) and Kleangas Energy Technologies Inc (OTCMKTS: KGET) have reported recent news and/or they are being promoted. Of course, it goes without saying that small cap green stocks tend to be more volatile that other types of investments. So will investors and traders alike see some greenbacks from these green stocks? Here is a quick reality check:

Top 5 Information Technology Companies To Own For 2015: Lender Processing Services Inc (LPS)

Lender Processing Services, Inc. provides integrated technology, data, and services to the mortgage lending industry in the United States. The company operates in two segments, Technology, Data, and Analytics; and Transaction Services. Its Technology, Data, and Analytics segment offers software systems and information solutions that facilitate and automate various business processes across the life cycle of a mortgage. This segment�s primary applications and services include mortgage servicing platform, an application that automates loan servicing, including loan setup and ongoing processing, customer service, accounting and reporting to the secondary mortgage market, and federal regulatory reporting; Desktop, a Web-based workflow information system that can be used for managing and automating various workflow processes; and other software applications and services that automate and facilitate the origination of mortgage loans. It also provides data and analytics services , such as alternative valuation services, and data and information. The company�s Transaction Services segment offers customized outsourced business process and information solutions. Its origination services include settlement and title agency services comprising centralized title agency and closing services; appraisal services; and other origination services, such as federal flood zone certifications and monitoring services. This segment also provides default management services, consisting of foreclosure administrative services, property inspection and preservation; default title and settlement services; and alternative property valuation services. The company serves mortgage originators and servicers, other financial institutions, investors, attorneys, trustees, and real estate professionals. Lender Processing Services, Inc. was incorporated in 2007 and is headquartered in Jacksonville, Florida.

Advisors' Opinion:
  • [By Holly LaFon]

    Despite economic and political turmoil, equity markets performed well across the board in September of 2013 and over the trailing twelve months. The September gains reversed losses in August and also resulted in positive overall quarterly performance with a number of major indexes moving further into record territory. After disturbing the markets in May and June with comments that they may taper Quantitative Easing (QE), the Fed surprised investors with an announcement that it would not reduce its asset purchases in the near-term. The announcement removed fears that a continued rise in interest rates may stall the economic recovery, as seen by the market's negative reaction to the sharp rise in the 10-year Treasury rate in August of 2013. Investors were also comforted by improving fundamentals both domestically and abroad. The Eurozone may finally be emerging from its prolonged recession and a number of economic reports in the U.S. continue to show progress. Specifically, initial unemployment claims dropped to a multiyear low early in September and the housing market continued to improve, as evidenced by prices rising 12.4 percent year-over year, which along with the stock market's strength, has created a positive wealth effect for consumers. In response to this general economic improvement, consumer confidence increased at the end of September, and the index of leading economic indicators ticked up as well, suggesting that, absent the effects of politics, the recovery in the real economy was continuing. Our portfolios that focus on corporate restructuring (Keeley Small Cap Value, Keeley Small-Mid Cap Value, Keeley Mid Cap Value, Keeley All Cap Value, and Keeley Alternative Value) have all experienced a productive investment cycle with respect to their opportunity sets, and many of our holdings have posted impressive results in recent quarters. Although we acknowledge an improving economy has boosted the outlook for our more cyclical holdings, our research has gu

Top 5 Information Technology Companies To Own For 2015: Gen-Probe Incorporated(GPRO)

Gen-Probe Incorporated engages in the development, manufacture, and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood. Its women?s health product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The company?s infectious diseases product line comprises ProFlu+ to detect influenza A, B, and Respiratory syncytial virus; ProFAST+ to detect and differentiate seasonal H1, seasonal H3, and H1N1pdm09; ProGastro Cd to detect toxigenic strains of clostridium difficile; AMPLIFIED MTD to detect mycobacterium tuberculosis; GAS Direct to detect gas directly from a throat swab; APTIMA HIV-1 and APTIMA HCV assays to detect RNA from HIV-1 and hepatitis C virus; and ASRs for quantitative HCV testing. Its blood screening products include Procleix HIV-1/HCV, Procleix Ultrio, Procleix Ultrio Plus, and Procleix WNV assays to detect HIV-1, HCV, HBV, and west nile virus in donated blood, plasma, organs, and tissues. The company?s transplant diagnostics products comprise LIFECODES HLA DNA typing kits; LIFECODES HLA antibody kits; LIFECODES PF4 assay to detect PF4 heparin-dependent antibodies; and LIFECODES PAK products for platelet antibody screening and detection. It also provides instrumentation and software for performing NAT assays; and genetic testing products, such as PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 genes. The company serves reference laboratories, public health institutions, and hospitals through its direct sales force in United States, Canada, and Europe, as well as through distributors internationally. Gen-Probe Incorporated was founded in 1983 and is headquartered in S an Diego, California.

Advisors' Opinion:
  • [By WWW.DAILYFINANCE.COM]

    www.gopro.com Now that it's nearly over, we can definitively say that 2014 has been one of the best years for initial public stock offerings in history. In terms of proceeds raised from IPOs, 2014 will challenge or even exceed the year 2000. Which is saying something: That was the height of the dot.com frenzy, when seemingly every new company with a website felt compelled to list on the stock exchange. As can be expected of a busy IPO year, some of 2014's new stock market titles have been runaway hits soaring above their issue price, while others have belly-flopped. Since we're heading into the most optimistic time of the year, we'll shine a light on the three best performers. In order of stock price appreciation, they are: GoPro (GPRO) 2014's current IPO front-runner is this company, maker of the popular action photography camera -- the one that's usually responsible for those hairy point-of-view videos posted on Facebook (FB) and other online sharing sites. GoPro's stock hit the market at the end of June priced at $24, and as if this writing it now stands at $70.72 for a muscular 195 percent total return. Although that's impressive, it should be noted that the current price is quite a bit lower than the stock's high of nearly $94, which it touched in early October. But then the camera was effectively blamed for the horrific accident that befell Formula One racing star Michael Schumacher -- although the journalist making the allegation later recanted -- and the shares cratered. The stock recovered after the company reported strong third-quarter earnings, and all seemed well again... until GoPro decided to float a secondary issue of stock. It'll sell 10.3 million fresh shares on the market, adding to the nearly 126 million currently outstanding. When secondary share issues are announced, a company's stock often takes a hit, since investors aren't too crazy about their existing stakes being diluted. Regardless, on a fundamental basis GoPro is a popular, if

Top 5 Information Technology Companies To Own For 2015: IntriCon Corporation(IIN)

IntriCon Corporation, through its subsidiaries, engages in the design, development, engineering, and manufacture of body-worn devices. It offers microelectronics, micro-mechanical assemblies, and injection-molded plastic components to medical device manufacturers of portable and lightweight battery powered devices; bio-telemetry devices, which include wireless continuous glucose monitors that measure glucose levels and provide real-time blood glucose trend information; and cardiac diagnostic monitoring devices. The company also provides bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and a family of safety needle products for original equipment manufacturing customers. In addition, it offers hybrid amplifiers and integrated circuit components along with faceplates for use in-the-ear and in-the-canal hearing instruments; and microminiature electromechanical components consisting of volume controls, microphone s, receivers, trimmer potentiometers, and switches to hearing instrument manufacturers. Further, the company provides professional audio headset products used for homeland security and emergency response applications in fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear and head-worn devices for use by performers and support staff in music and stage performance markets. It markets its products directly through its internal sales force in the United States, as well as through sales representative primarily in Europe and the Asian Pacific. IntriCon Corporation has strategic alliances with Dynamic Hearing Pty Ltd. to use its technology for the development of new body-worn ULP-DSP applications; and Advanced Medical Electronics Corp. to develop new bio-telemetry devices. The company, formerly known as Selas Corporation of America, was founded in 1930 and is headquartered in Arden Hills, Minnesota.

Advisors' Opinion:
  • [By Lisa Levin]

    Intricon (NASDAQ: IIN) shares gained 33.98% to touch a new 52-week high of $6.23 after the company reported Q1 results.

    Abraxas Petroleum (NASDAQ: AXAS) shares gained 2.19% to reach a new 52-week high of $5.60. Abraxas Petroleum shares have jumped 154.88% over the past 52 weeks, while the S&P 500 index has gained 18.57% in the same period.

Wednesday, June 3, 2015

Top 5 Industrial Disributor Companies To Watch For 2015

Shares of medical robotics maker Intuitive Surgical (NASDAQ: ISRG  ) are in free-fall today after yesterday's earnings, with the stock plummeting 4.7% after losing a bundle yesterday as well. Earnings aren't the disappointment, however: Intuitive destroyed analyst expectations and showed solid growth in both procedures and device sales. Investors haven't been so kind to the stock, however, and with shares of the company down almost 8% in the last five days alone, it's time to ask: Why is everyone selling this stock?

Investors in a panic attack
The company's financial footing certainly isn't the culprit. Intuitive drilled earnings-per-share expectations, topping projections by $0.58 and beating revenue estimates by almost $30 million. The firm also racked up double-digit growth in both categories over the quarter a year ago, including growth of more than 30% in EPS.

So, what's really behind Intuitive's fall? It's fear.

The company has been in the spotlight recently with concerns mounting about the safety of robotic surgery. Shares weren't helped when the Food and Drug Administration announced it would investigate the company's da Vinci surgical device's complaints, looking to evaluate if the costly machine (da Vinci devices cost around $1.5 million each) added any value over traditional surgeries. That was enough to spark fear among investors, who have panicked over the thought that robotic surgery could come under fire by safety regulators. The FDA's investigation isn't an indictment, however; it's simply a follow-up on complaints.

Top 10 Investments For 2016: BioDelivery Sciences International Inc.(BDSI)

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. The BEMA technology is a small erodible polymer film for application to the buccal mucosa; and the Bioral cochleate drug delivery technology encapsulates a selected drug or therapeutic in a cochleate cylinder. Its pain franchise consists of products utilizing the patented BEMA technology, including ONSOLIS, a fentanyl buccal soluble film for the management of pain in opioid tolerant adult patients with cancer; and BEMA Buprenorphine, which is in the development stage for the treatment of moderate to severe chronic pain, as well as for the treatment of opioid dependence. The company also engages in developing product candidates utilizing the B EMA technology for conditions, such as nausea/vomiting. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

Advisors' Opinion:
  • [By John Kell]

    Shares of BioDelivery Sciences International Inc.(BDSI) jumped after the company disclosed favorable results for a Phase 3 study of a treatment for severe chronic pain. BioDelivery shares surged 45% to $9.04 premarket.

Top 5 Industrial Disributor Companies To Watch For 2015: Petroleo Brasileiro Petrobras SA (PBR.A)

Petroleo Brasileiro SA Petrobras (Petrobras) is a Brazilian integrated oil and gas company. It operates in five segments: exploration and production; refining, commercialization and transport of oil and natural gas; petrochemicals; distribution of derivatives, electrical energy, biofuels and other renewable energy sources. Directly or through its subsidiaries, Petrobras is engaged in the research, extraction, refining, processing, commercialization and transport of oil from wells, shales and other rocks, its derivatives, natural gas and other liquid hydrocarbons, as well as in activities related to energy, promoting research, development, production, transport, distribution and commercialization of all forms of energy. As of December 31, 2010, it had 132 production platforms, 16 refineries, 291 vessels, 29,398 kilometers of pipelines, six biofuel plants, 16 thermoelectric plants, one pilot wind farm, 8,477 service stations and two fertilizer plants, as well as presence in 30 countries.

Exploration and Production

The domestic oil and gas exploration and production efforts are focused on the three basins offshore in Southeastern Brazil: Campos, Espirito Santo and Santos. The Campos Basin, which covers approximately 115,000 square kilometers (28.4 million acres) is the oil and gas basin in Brazil. At December 31, 2009, the Company was producing from 41 fields at an average rate of 1,693.6 mbbl/d of oil and held proved crude oil reserves representing 90% of the total proved crude oil reserves in Brazil. At December 31, 2009, the Company held proved natural gas reserves in the Campos Basin representing 53% of the total proved natural gas reserves in Brazil. It operated 38 floating production systems, 14 fixed platforms and 5,472 kilometers (3,400.3 miles) of pipeline and flexible pipes in water depths from 80 to 1,886 meters (262 to 6,188 feet). At December 31, 2009, the Company held exploration rights to 21 blocks in the Campos Basin, comprising 5884 square kilometers (1.4 millio! n acres)..

Petrobras have made discoveries of light oil and natural gas in the Espirito Santo Basin, which covers approximately 75000 square kilometers (18.5 million acres) offshore and 14,000 square kilometers (3.5 million acres) onshore. At December 31, 2009, the Company was producing from 46 fields at an average rate of 40.9 thousand barrels per day (mbbl/d) and held proved crude oil reserves, representing 1% of the total proved crude oil reserves in Brazil. On December 31, 2009, the Company held exploration rights to 23 blocks, six onshore and 17 offshore, comprising 8623 square kilometers (2.1 million acres).

The Santos Basin covers approximately 348,900 square kilometers (86 million acres) off the city of Santos, in the State of Sao Paulo. At December 31, 2009, the Company produced oil from two fields and one exploration area at an average rate of 14.4 mbbl/d and held proved crude oil reserves representing 1% of the total proved crude oil reserves in Brazil. It produces hydrocarbons and hold exploration acreage in eight other basins in Brazil.

Refining, Transportation and Marketing

As of December 31, 2009, the Company operated 92% of Brazil�� total refining capacity and supplied almost all of the refined product needs of third-party wholesalers, exporters and petrochemical companies. As of December 31, 2009, the Company owned and operated 11 refineries in Brazil, with a total net distillation capacity of 1,942 mbbl/d. It operates an infrastructure of pipelines and terminals and a shipping fleet to transport oil products and crude oil to domestic and export markets. The refineries are located near the crude oil pipelines, storage, facilities, refined product pipelines and petrochemical facilities, facilitating access to crude oil supplies and other users.The segment also includes petrochemical and fertilizer operations. As at December 31, 2009, the refining capacity in Brazil was 1,942 mbbl/d and the average throughput was 1,791 mbbl/d.

T! he Company owns and operates a network of crude oil and oil products pipelines in Brazil that connect the terminals, refineries and other primary distribution points. On December 31, 2009, the onshore and offshore, crude oil and oil products pipelines extended 13,996 kilometers (8,698 miles). It operates 27 marine storage terminals and 20 other tank farms with nominal aggregate storage capacity of 65 million barrels. The marine terminals handle an average 10,000 tankers annually.

The Company operates a fleet of owned and chartered vessels. It provides shuttle services between the producing basins offshore Brazil and the Brazilian mainland, domestic shipping and international shipping to other parts of South America, the Caribbean Sea and Gulf of Mexico, Europe, West Africa and the Middle East. The fleet includes double-hulled vessels and single-hulled vessels, which operate in South America and Africa only.

Distribution

The distribution segment sells oil products, which are produced by the supply operations. At December 31, 2009, the BR network included 7,221 service stations, or 19.2% of the stations in Brazil. The Company supplies and operates Petrobras Distribuidora S.A., which accounts for 38% of the total Brazilian distribution market. BR distributes oil products, ethanol and biodiesel, and vehicular natural gas to retail, commercial and industrial customers. In 2009, BR sold the equivalent of 767.4 mbbl/d of oil products and other fuels to wholesale and retail customers.

The Company also distributes oil products and biofuels under the BR brand to commercial and industrial customers. The customers include aviation, transportation and industrial companies, as well as utilities and government entities. It also sells oil products produced by the Supply operations to other retailers and to wholesalers.

Gas and Power

The natural gas business includes four activities: transportation (building and operating natural gas pipel! ine netwo! rks in Brazil), acquisition and regasification of LNG, equity participation in distribution companies, which sell natural gas to the users, and commercialization (purchase and resale). In January 2009, the Company completed construction of two LNG terminals, one in Rio de Janeiro with a send-out capacity of 20 mmm3 /d (706 mmcf/d).

International

The Company have operations in 24 countries outside Brazil, which encompasses all phases of the energy business. It is focusing the international upstream activities in the Gulf of Mexico and West Africa. During 2009, the Company conducted exploration and production activities in 21 countries outside Brazil (Angola, Argentina, Bolivia, Colombia, Ecuador, the United States, India, Iran, Libya, Mexico, Mozambique, Namibia, Nigeria, Pakistan, Peru, Portugal, Senegal, Tanzania, Turkey, Uruguay and Venezuela). At December 31, 2009, the total assets of the International Segment represented 7.4% of the Company�� total assets.

Advisors' Opinion:
  • [By Rudy Martin]

    In addition, we recommend buying shares in Brazilian energy giant Petroleo Brasileiro Petrobras S.A. (PBR.A).

    Despite a gradual rise in crude oil prices, problems with Brazil's economy, compounded by obstacles in Petrobras's scramble to finance significant on-shore and off-shore hydrocarbon discoveries, have ganged up to erode PBR.A's stock price this year.

Top 5 Industrial Disributor Companies To Watch For 2015: Celldex Therapeutics Inc(CLDX)

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. The company markets Rotarix to treat rotavirus infection. Its lead drug candidate, rindopepimut (CDX-110), is an immunotherapeutic vaccine in Phase III clinical trial to target the tumor-specific molecule, epidermal growth factor receptor variant III, as well as in Phase II clinical trial for the indication of recurrent glioblastoma. The company?s other lead drug candidates comprise CDX-011, an antibody-drug conjugate in Phase IIb clinical trial for metastatic breast cancer and melanoma indication; and CDX-1127, a human monoclonal antibody in Phase I clinical trial for the treatment of lymphoma/leukemia and solid tumors. Its additional clinical and preclinical programs consist of CDX-1401, an Antigen Presenting Cells Targeting Technology program in Phase I/II clinical trial to tr eat multiple solid tumors; and CDX-301, an immune cell mobilizing agent and dendritic cell growth factor in Phase I clinical for treating cancer, autoimmune disease, and transplant. The company?s preclinical products include CDX-1135, a molecule for treating renal disease; and CDX-014, a human monoclonal antibody-drug conjugate for the treatment of ovarian and renal cancer. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; Thomas Jefferson University; 3M Company; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. Celldex Therapeutics, Inc. was founded in 1983 and is headquartered in Needham, Massachusetts.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Celldex Therapeutics (NASDAQ: CLDX) shares tumbled 9.36 percent to $25.66 after the company reported positive Phase 2 rindopepimut data in patients with recurrent glioblastoma.

  • [By Bryan Murphy]

    A week ago, yours truly recommended adding EnteroMedics Inc. (NASDAQ:ETRM), Arrowhead Research Corp. (NASDAQ:ARWR), and Celldex Therapeutics, Inc. (NASDAQ:CLDX) to your watchlist, all as bullish candidates. Although ETRM was a bust, CLDX and ARWR are both still compelling. In fact, those two survivors merit an updated look, as each has moved further along its bullish path, and each looks like it's itching to put the pedal to the metal.

  • [By Luke Jacobi]

    Celldex Therapeutics (NASDAQ: CLDX) gained 12.91 percent to $32.70 after a bullish report out of Leerink Swann.

    Shares of Pandora (NYSE: P) lost 10.11 percent to $24.26 as traders looked to take profit on the stock after shares posted a massive rally over the past 3 weeks.

  • [By Bryan Murphy]

    If you're looking to get the new trading year started on the right foot, then you may want to keep Celldex Therapeutics, Inc. (NASDAQ:CLDX), EnteroMedics Inc. (NASDAQ:ETRM), and Arrowhead Research Corp. (NASDAQ:ARWR) in your back pocket if not in your portfolio. Why? Because these three small cap stocks are positioned to deliver big breakouts, if they're not already doing so. Here's a closer look at each, and exactly what you need to watch for with CLDX, ARWR, and ETRM.

Top 5 Industrial Disributor Companies To Watch For 2015: SeaChange International Inc.(SEAC)

SeaChange International, Inc. provides multi-screen video products and services that facilitate the aggregation, licensing, management, and distribution of video, television programming, and advertising content to cable system operators, telecommunications companies, broadcast television companies, and mobile communications providers worldwide. The company operates in two segments, Software and Media Services. The Software segment offers back-office products, including SeaChange Axiom, an on-demand back office software that allow operators to centralize video distribution systems, as well as video streamers; advertising product solutions, such as video-on-demand, digital video recorders, and over-the-top services; and home gateway product solutions, which include Nucleus, a hybrid gateway software product that provides control over channel changes, VOD/DVR playback, and trick mode set-top box functionalities. This segment also provides professional services, installation, training, project management, product maintenance, technical support, and software development related services. The Media Services segment offers content for video-on-demand and pay-per-view platforms; and marketing, promotional, and production services to cable operators and telecommunications providers. This segment also sources, acquires, packages, and markets video-on-demand services by providing access to content from local and Hollywood studio providers in various formats, including music videos, television programs, and feature length movies. The company sells and markets its products and services through a direct sales organization, independent agents, and distributors. SeaChange International, Inc. was founded in 1993 and is headquartered in Acton, Massachusetts.

Advisors' Opinion:
  • [By Monica Gerson]

    SeaChange International (NASDAQ: SEAC) is estimated to post a Q2 loss at $0.18 per share on revenue of $26.80 million.

    China Gerui Advanced Materials Group (NASDAQ: CHOP) is expected to report its Q2 earnings.

  • [By Johanna Bennett]

    SeaChange (SEAC) fell 16.5% to $12.03 after the company’s guidance for the fiscal fourth quarter fell well below analysts’ expectations.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SeaChange International (Nasdaq: SEAC  ) , whose recent revenue and earnings are plotted below.

Tuesday, June 2, 2015

5 Best Gas Utility Stocks To Invest In 2015

Popular Posts: 3 Cash-Rich Stocks to Buy Now3 Legendary Names to Hold for Retirement3 Unexpected Stocks to Buy in a Market Crash Recent Posts: 3 Unexpected Stocks to Buy in a Market Crash 3 Naked Puts Worth a Cool $1,000 in Income PriceSmart (PSMT): Plenty of Growth … But at What Cost? View All Posts

Everyone seems to be speculating that a major correction is coming to the stock market. We had an outstandingly good year in 2013, industries like tech and biotech are selling off, and we seem due for a significant dip.

Top Dividend Stocks To Own For 2016: Pharmacyclics Inc (PCYC)

Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton�� tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.

As of June 30, 2012, the Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.

Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).

PCI-27483 Factor VIIa Inhibitor

The Company�� Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.

Factor VIIa PCI-27483 Clinical Development Update

A multicenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.

A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.

Advisors' Opinion:
  • [By Ben Levisohn]

    [The] sell-off in recent days was broad based and…affecting stocks in direct relationship to their volatility and expected duration of negative cash flow. Small and mid cap stocks were most affected (especially post-IPO stocks), and those with major uncertain events looming (MDVN) or with significant revenue upside already built into valuation (PCYC) were among the most severely affected. However, nothing changed in the environment to suggest that those events were any more or less likely to have positive outcomes yesterday, or to suggest that revenue potential was any more or less likely to be achieved than was previously expected.

5 Best Gas Utility Stocks To Invest In 2015: UnitedHealth Group Incorporated(UNH)

UnitedHealth Group Incorporated provides healthcare services in the United States. Its Health Benefits segment offers consumer-oriented health benefit plans and services to national employers, public sector employers, mid-sized employers, small businesses, and individuals; and non-employer based insurance options for purchase by individuals. It also provides health and well-being services for individuals aged 50 and older; and for services dealing with chronic disease and other specialized issues for older individuals, as well as health plans for the beneficiaries of acute and long-term care Medicaid plans. This segment offers its services through a network of 730,000 physicians and other health care professionals, and 5,300 hospitals. Its OptumHealth segment provides health, financial, and ancillary services and products that assist consumers through personalized health management solutions; benefit administration, and clinical and network management; health-based financi al services; behavioral solutions; and specialty benefits, such as dental, vision, life, critical illness, short-term disability, and stop-loss product offerings. The company?s Ingenix segment offers database and data management services, software products, publications, consulting and actuarial services, business process outsourcing services, and pharmaceutical data consulting and research services. Its Prescription Solutions segment provides integrated pharmacy benefit management services comprising retail network pharmacy contracting and management, claims processing, mail order pharmacy services, specialty pharmacy, benefit design consultation, rebate contracting and management, drug utilization review, formulary management programs, disease therapy management, and adherence programs to employer groups, union trusts, managed care organizations, Medicare-contracted plans, Medicaid plans, and third party administrators. The company was founded in 1974 and is based in Minne tonka, Minnesota.

Advisors' Opinion:
  • [By Keith Speights]

    Perhaps the best proof that the core idea of the Obamacare ACO program can be successful is in adoption by health insurers that must show shareholders they're managing care effectively. The nation's largest health insurer, UnitedHealth Group (NYSE: UNH  ) , decided to expand its accountable care initiatives. UnitedHealth expects to have accountable care contracts totaling $65 billion in annual reimbursements by 2018 -- more than double the current level.�

  • [By Ben Levisohn]

    We’ve looked at new Harvoni patient authorization forms from Anthem (Express Scripts (ESRX) is the pharmacy benefit provider) and UnitedHealth (UNH) that just came out… We note they have headline language “approval criteria” that reads and attempts to limit/restrict coverage to only the sicker highest risk F3-4 patients. The forms do support 8-12 weeks of Harvoni therapy. Separately, (2) Senator Bernard Sanders is planning a hearing before year end to examine HCV costs to the Dept of Veterans Affairs (VA=10% max HCV volume) which could add some headline risk to be aware of that reminds us of Waxman…

  • [By Jeremy Bowman]

    UnitedHealth (NYSE: UNH  ) shares were also looking brighter today, gaining 2.2% after JPMorgan Chase upgraded its rating on UnitedHealth and Humana to overweight, saying the insurance providers should be able to grow their Medicare Advantage enrollment in spite of potential reimbursement cuts. UnitedHealth shares have bounced up and down this year as the government has changed its expected cut to the program from 8% to 4%.

5 Best Gas Utility Stocks To Invest In 2015: Checkpoint Systms Inc.(CKP)

Checkpoint Systems, Inc. manufactures and markets identification, tracking, security, and merchandising solutions for the retail and apparel industry worldwide. The company operates in three segments: Shrink Management Solutions, Apparel Labeling Solutions, and Retail Merchandising Solutions. The Shrink Management Solutions segment provides shrink management and merchandise visibility solutions. It offers electronic article surveillance systems, such as EVOLVE, a suite of RF and RFID-enabled products that act as a deterrent to prevent merchandise theft in retail stores; and electronic article surveillance consumables, including EAS-RF and EAS-EM labels that work in combination with EAS systems to reduce merchandise theft in retail stores. This segment also provides keepers, spider wraps, bottle security, and hard tags, as well as Showsafe, a line alarm system for protecting display merchandise. In addition, it offers physical and electronic store monitoring solutions, incl uding fire alarms, intrusion alarms, and digital video recording systems for retail environments; and RFID tags and labels. The Apparel Labeling Solutions segment provides apparel labeling solutions to apparel retailers, brand owners, and manufacturers. It has Web-enabled apparel labeling solutions platform and network of 28 service bureaus located in 22 countries that supplies customers with customized apparel tags and labels. The Retail Merchandising Solutions segment offers hand-held label applicators and tags, promotional displays, and queuing systems. The company serves retailers in the supermarket, drug store, hypermarket, and mass merchandiser markets through direct distribution and reseller channels. Checkpoint Systems was founded in 1969 and is based in Thorofare, New Jersey.

Advisors' Opinion:
  • [By Lisa Levin]

    Checkpoint Systems (NYSE: CKP) surged 17.73% to $14.21. The volume of Checkpoint Systems shares traded was 525% higher than normal. Checkpoint announced its intent to extend the filing date of its annual report.

5 Best Gas Utility Stocks To Invest In 2015: Globalstar Inc.(GSAT)

Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers various communications services, including fixed voice and data satellite communications services; and satellite data modem services for asset-tracking applications, which enables customers to control directly their remote assets and perform complicated monitoring activities. It also offers duplex two-way transmission products comprising GSP-1720 satellite voice and data modem boards, which enable resellers to integrate the satellite modem processing with the specific application; SPOT satellite GPS messenger for tracing geographically, or mapping the location of individuals or equipment; and SPOT satellite communicators. In addition, Globalstar, Inc. provides SPOT HUG, a device for monitoring of a boat's location, status of the operations, engine, pumps, hatch, and door status, as well as valuables onboard; SPOT Connect, a one-way messaging device that s ends messages through the company?s satellite network from smartphone or other smart devices, such as tablets; and simplex one-way transmission products. The company sells its products primarily to government; public safety and disaster relief; recreation and personal; oil and gas; maritime and fishing; natural resources, mining, and forestry; construction; utilities; and transportation markets. Globalstar, Inc. distributes its products through independent agents, dealers, and resellers, as well as independent gateway operators. It operates approximately 34 in-orbit satellites and 25 ground stations. The company was founded in 2003 and is headquartered in Covington, Louisiana.

Advisors' Opinion:
  • [By James E. Brumley]

    If you don't have Cyren Ltd (NASDAQ:CYRN), Globalstar, Inc. (NYSEMKT:GSAT), or Ossen Innovation Co Ltd (NASDAQ:OSN) on your radar, put them on there quick. All three stocks are knocking on the door of bigger (read "trade-worthy") moves at a point in time where big moves are rare... not to mention a period on the calendar that slightly favors small cap stocks. To then end, here's a closer look at why GSAT, CYRN, and OSN may be better than average bets here.

Monday, June 1, 2015

Top 10 Cheapest Companies To Invest In Right Now

Top 10 Cheapest Companies To Invest In Right Now: Meritage Homes Corp (MTH)

Meritage Homes Corporation, incorporated on May 26 1988, operates as holding company. The Company through its subsidiaries is a designer and builder of single-family detached homes based on the number of home closings. The Company primarily builds in regions of the western and southern United States and offer a variety of homes that are designed to appeal to a range of homebuyers, including first-time, move-up, active adult and luxury. It has operations in three regions: West, Central and East, which consists of seven states: Arizona, California, Nevada, Texas, Colorado, Florida, and the Carolinas. Operations within the Carolinas include the Raleigh and Charlotte metropolitan areas, with some Charlotte communities located across the border into South Carolina. These three regions are its principal business segments. The Company's homebuilding and marketing activities are conducted under the Meritage Homes brand, except for Arizona and Texas where it operates under the na me Monterey Homes. As of December 31, 2012, it was selling homes in 158 communities. Effective September 4, 2013, Meritage Homes Corporation acquired Phillips Builders Inc from Beazer Homes USA Inc.

The Company's homes range from entry level to luxury. The Company purchases a combination of finished lots and partially-developed or undeveloped lots. As of December 31, 2012, in addition to its approximately 17,500 owned lots, it also had approximately 3,300 committed lots under option or contract. It also participates in three mortgage and one title business joint ventures. The mortgage joint ventures are engaged in mortgage activities, and they provide services to both its customers and other homebuyers. The Company acts as a general contractor.

Advisors' Opinion:
  • [By James E. Brumley]

    Given the bad news reg! arding new-home sales unveiled  this morning, it's no real surprise that homebuilder stocks like KB Home (NYSE:KBH) and M/I Homes Inc. (NYSE:MHO) are struggling. KBH is down 2.8% as of the last look, while MHO shares are off 4.1%. None of the major homebuilder names are underwater as much as Meritage Homes Corp. (NYSE:MTH) is today, though, with its 8.6% drubbing. Already struggling, today's stumble from MTH may well jump-start a more serious selloff that the bulls have thus far been able to stave off.

  • [By Paul Ausick]

    Of five stocks we looked at, only one shows a gain over the past 12 months. Meritage Homes Corp. (NYSE: MTH) has a market cap of $1.68 billion and the stock closed at $45.39 last Friday, in a 52-week range of $38.42 to $52.95. The stock is up more than 8% over the past 12 months. The consensus price target is around $50.10, which indicates an implied gain of about 10%, about half the implied gain we saw in December. Meritage has easily beaten EPS in each of the past four quarters. Shares were up nearly about 0.8% at $45.82 on Monday morning. Meritage reports earnings on February 5 and is expected to post EPS of $1.03 on revenues of $537.3 million.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-cheapest-companies-to-invest-in-right-now-2.html

Sunday, May 31, 2015

Top Shipping Stocks To Buy For 2016

Top Shipping Stocks To Buy For 2016: Cardtronics Inc.(CATM)

Cardtronics, Inc., together with its subsidiaries, provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. As of December 31, 2011, it offered services to approximately 52,900 devices across its portfolio, which included approximately 46,000 devices located in 50 states of the United States, as well as in the U.S. territories of Puerto Rico and the U.S. Virgin Islands; approximately 3,500 devices throughout the United Kingdom; approximately 2,800 devices throughout Mexico; and approximately 600 devices in Canada. The company also deployed approximately 2,200 multi-function financial services kiosks in the United States. Its ATMs and financial services kiosks offer cash dispensing and bank account balance inquiry services, as well as other consumer financial services, including bill payments, check cashing, remote deposit capture, and money transfer services. In addition, the compan y provides various forms of managed service solution, including monitoring, maintenance, cash management, customer service, and transaction processing services. Further, it partners with national financial institutions to brand its ATMs and financial services kiosks with their logos. As of December 31, 2011, the company had approximately 15,400 company-owned ATMs under contract with financial institutions to place their logos on those machines. Additionally, it provides financial institutions with surcharge-free program through its Allpoint network, as well as owns and operates an electronic funds transfer transaction processing platform that provides transaction processing services to its network of ATMs and financial services kiosks, and ATMs owned and operated by third parties. The company was formerly known as Cardtronics Group, Inc. and changed its name to Cardtronics, Inc. i! n January 2004. Cardtronics, Inc. was founded in 1989 and is headquartered in Houston, Texas.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Cardtronics (Nasdaq: CATM  ) , whose recent revenue and earnings are plotted below.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-shipping-stocks-to-buy-for-2016.html